News & Updates

Show Multimedia Only

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

Symptoms for ARIs in children vary across age groups

01 Jul 2025

Acute respiratory infections (ARIs) are associated with various symptoms across different age groups, according to a Korea study.

Symptoms for ARIs in children vary across age groups

01 Jul 2025

MMP7 predicts progression, death in antifibrotic-treated IPF

28 Jun 2025 by

Higher levels of matrix metalloprotease 7 (MMP7) pretreatment are predictive of 12-month progression and mortality among patients with idiopathic pulmonary fibrosis (IPF) who have been treated with antifibrotics, reveals a recent study.

MMP7 predicts progression, death in antifibrotic-treated IPF

28 Jun 2025

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

New drug applications approved by US FDA as of 16-31 May 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 May 2025)

23 Jun 2025

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

In the treatment of adults with acute, uncomplicated influenza infections, onradivir appears to provide similar curative efficacy as oseltamivir while having an acceptable safety profile, as shown in a phase III study.

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

21 Jun 2025 by

Hypoglossal nerve stimulation is safe and effective for reducing apnoea-hypopnoea index (AHI) in Asian patients with obstructive sleep apnoea (OSA), according to early experience from a single tertiary Singaporean sleep centre.

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

21 Jun 2025

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025 by

The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025 by

The investigational influenza–COVID-19 combination vaccine mRNA-1083 has demonstrated noninferiority to recommended standard-care flu and COVID-19 vaccines, with higher immune responses and an acceptable safety profile in adults at least 50 years of age, according to the results of a phase III trial.

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025 by

The use of methotrexate as a first line of treatment for patients with pulmonary sarcoidosis delivers similar efficacy to prednisone as measured by forced vital capacity after 24 weeks, results of the PREDMETH trial have shown.

First-line methotrexate on par with prednisone for sarcoidosis

18 Jun 2025

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025 by

A novel digital psychological therapy, named Almee, demonstrates efficacy in improving health-related quality of life (HRQOL) in patients with pulmonary fibrosis, irrespective of antifibrotic treatment use, reports a study presented at ATS 2025.

Digital therapy improves life quality of patients with pulmonary fibrosis

18 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Short-course antibiotic for paediatric CAP on par with long-course regimen

Short-course antibiotic for paediatric CAP on par with long-course regimen

Symptoms for ARIs in children vary across age groups

Symptoms for ARIs in children vary across age groups

MMP7 predicts progression, death in antifibrotic-treated IPF

MMP7 predicts progression, death in antifibrotic-treated IPF

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Original New Drug Application Approvals by US FDA (16-31 May 2025)

Onradivir as good as oseltamivir for acute, uncomplicated flu

Onradivir as good as oseltamivir for acute, uncomplicated flu

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

Asians with sleep apnoea fare well with hypoglossal nerve stimulation

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

First-line methotrexate on par with prednisone for sarcoidosis

First-line methotrexate on par with prednisone for sarcoidosis

Digital therapy improves life quality of patients with pulmonary fibrosis

Digital therapy improves life quality of patients with pulmonary fibrosis